Vinblastine-loaded platelets for autoimmune hemolytic anemia

Morie Gertz, R. M. Petitt, A. A. Pineda, M. R. Wick, E. A. Burgstaler

Research output: Contribution to journalArticle

10 Scopus citations


Treatment of autoimmune hemolytic anemia with corticosteroids, splenectomy, immune suppression, and plasma exchange, serially or in combination, often yields partial or short remissions. We describe a patient in whom refractory autoimmune hemolytic anemia was moderated by selective impairment of the mononuclear-phagocyte system by means of infusion of vinblastine-loaded platelets. The success of this approach, initially proposed for treatment of immune thrombocytopenic purpura, suggests that erythrocytes and platelets share a common site of immune destruction and that the rate of this destruction is determined by the phagocyte.

Original languageEnglish (US)
Pages (from-to)325-326
Number of pages2
JournalUnknown Journal
Issue number3
StatePublished - Jan 1 1981

ASJC Scopus subject areas

  • Internal Medicine

Fingerprint Dive into the research topics of 'Vinblastine-loaded platelets for autoimmune hemolytic anemia'. Together they form a unique fingerprint.

Cite this